QQ客服 官方微博 反馈留言

	ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.
	Ting Guo; Xian-Zi Wen; Zi-Yu Li; Hai-Bo Han; Chen-Guang Zhang; Yan-Hua Bai; Xiao-Fang Xing; Xiao-Jing Cheng; Hong Du; Ying Hu
刊名	Cell death & disease
	2019
卷号	Vol.10 No.2页码:33
ISSN号	2041-4889
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4604828
专题	湖南大学
作者单位	1.Key Laboratory of Carcinogenesis and Translational Research , Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & 2.Institute, Beijing, China. Department of Gastrointestinal Surgery, Peking University Cancer Hospital & 3.Institute, Beijing, China. The Tissue Bank, Peking University Cancer Hospital & 4.Institute, Beijing, China. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. Department of Pathology, Peking University Cancer Hospital & 5.Institute, Beijing, China. Key Laboratory of Carcinogenesis and Translational Research , Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & 6.Institute, Beijing, China. jijiafu@hsc.pku.edu.cn. Department of Gastrointestinal Surgery, Peking University Cancer Hospital & 7.Institute, Beijing, China. jijiafu@hsc.pku.edu.cn.
推荐引用方式 GB/T 7714	Ting Guo,Xian-Zi Wen,Zi-Yu Li,et al. ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.[J]. Cell death & disease,2019,Vol.10 No.2:33.
APA	Ting Guo.,Xian-Zi Wen.,Zi-Yu Li.,Hai-Bo Han.,Chen-Guang Zhang.,...&Jia-Fu Ji.(2019).ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7..Cell death & disease,Vol.10 No.2,33.
MLA	Ting Guo,et al."ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.".Cell death & disease Vol.10 No.2(2019):33.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。